Triple-negative breast cancer (TNBC), defined by lack of therapeutic targets (estrogen receptor, progesterone receptor, and Her2), is considered to be a form of breast cancer with more aggression and poorer prognosis82. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.